JP2011528896A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011528896A5 JP2011528896A5 JP2011519186A JP2011519186A JP2011528896A5 JP 2011528896 A5 JP2011528896 A5 JP 2011528896A5 JP 2011519186 A JP2011519186 A JP 2011519186A JP 2011519186 A JP2011519186 A JP 2011519186A JP 2011528896 A5 JP2011528896 A5 JP 2011528896A5
- Authority
- JP
- Japan
- Prior art keywords
- tuberculosis
- prevention
- protein sequence
- treatment
- rv2386c protein
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 201000008827 tuberculosis Diseases 0.000 claims 26
- 101100456232 Mycobacterium tuberculosis (strain ATCC 25618 / H37Rv) mbtI gene Proteins 0.000 claims 24
- 239000003814 drug Substances 0.000 claims 22
- 230000002265 prevention Effects 0.000 claims 22
- 229920001184 polypeptide Polymers 0.000 claims 10
- 102000004196 processed proteins & peptides Human genes 0.000 claims 10
- 108090000765 processed proteins & peptides Proteins 0.000 claims 10
- 230000002163 immunogen Effects 0.000 claims 9
- 239000012634 fragment Substances 0.000 claims 8
- 206010065048 Latent tuberculosis Diseases 0.000 claims 5
- 108091033319 polynucleotide Proteins 0.000 claims 5
- 102000040430 polynucleotide Human genes 0.000 claims 5
- 239000002157 polynucleotide Substances 0.000 claims 5
- 108091028043 Nucleic acid sequence Proteins 0.000 claims 4
- 150000007523 nucleic acids Chemical group 0.000 claims 4
- 230000007420 reactivation Effects 0.000 claims 4
- 230000003111 delayed effect Effects 0.000 claims 2
- 108020001507 fusion proteins Proteins 0.000 claims 2
- 102000037865 fusion proteins Human genes 0.000 claims 2
- 238000004519 manufacturing process Methods 0.000 claims 2
- 208000036981 active tuberculosis Diseases 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 239000003623 enhancer Substances 0.000 claims 1
- 230000015788 innate immune response Effects 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 239000002773 nucleotide Substances 0.000 claims 1
- 125000003729 nucleotide group Chemical group 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US8369908P | 2008-07-25 | 2008-07-25 | |
| US61/083,699 | 2008-07-25 | ||
| PCT/EP2009/059585 WO2010010179A1 (en) | 2008-07-25 | 2009-07-24 | The tuberculosis rv2386c protein, compositions and uses thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015134587A Division JP6104326B2 (ja) | 2008-07-25 | 2015-07-03 | 結核Ｒｖ２３８６ｃタンパク質、組成物およびその使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2011528896A JP2011528896A (ja) | 2011-12-01 |
| JP2011528896A5 true JP2011528896A5 (enExample) | 2012-09-06 |
| JP5981138B2 JP5981138B2 (ja) | 2016-08-31 |
Family
ID=41227131
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011519186A Active JP5981138B2 (ja) | 2008-07-25 | 2009-07-24 | 結核Ｒｖ２３８６ｃタンパク質、組成物およびその使用 |
| JP2015134587A Expired - Fee Related JP6104326B2 (ja) | 2008-07-25 | 2015-07-03 | 結核Ｒｖ２３８６ｃタンパク質、組成物およびその使用 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2015134587A Expired - Fee Related JP6104326B2 (ja) | 2008-07-25 | 2015-07-03 | 結核Ｒｖ２３８６ｃタンパク質、組成物およびその使用 |
Country Status (23)
| Country | Link |
|---|---|
| US (4) | US20110206712A1 (enExample) |
| EP (1) | EP2315834B1 (enExample) |
| JP (2) | JP5981138B2 (enExample) |
| KR (1) | KR20110049834A (enExample) |
| CN (2) | CN102165064B (enExample) |
| AU (1) | AU2009273132B2 (enExample) |
| BR (1) | BRPI0916704A2 (enExample) |
| CA (1) | CA2731547C (enExample) |
| CO (1) | CO6351811A2 (enExample) |
| CY (1) | CY1121632T1 (enExample) |
| DK (1) | DK2315834T3 (enExample) |
| EA (1) | EA201100070A1 (enExample) |
| ES (1) | ES2685498T3 (enExample) |
| HR (1) | HRP20181353T1 (enExample) |
| HU (1) | HUE039159T2 (enExample) |
| IL (1) | IL210589A (enExample) |
| LT (1) | LT2315834T (enExample) |
| MX (1) | MX2011000982A (enExample) |
| PL (1) | PL2315834T3 (enExample) |
| PT (1) | PT2315834T (enExample) |
| SI (1) | SI2315834T1 (enExample) |
| UA (1) | UA107329C2 (enExample) |
| WO (1) | WO2010010179A1 (enExample) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2649688A1 (en) * | 2006-03-14 | 2007-09-20 | Oregon Health & Science University | Methods for detecting a mycobacterium tuberculosis infection |
| US20110189217A1 (en) * | 2008-06-26 | 2011-08-04 | Barry Michael A | Methods and materials for producing immune responses against polypeptides involved in antibiotic resistance |
| LT2315597T (lt) | 2008-07-25 | 2018-02-12 | Glaxosmithkline Biologicals S.A. | Naujos kompozicijos ir būdai |
| PT2315834T (pt) | 2008-07-25 | 2018-08-10 | Glaxosmithkline Biologicals Sa | A proteína rv2386c de tuberculose, composições e as suas utilizações |
| GB201116248D0 (en) | 2011-09-20 | 2011-11-02 | Glaxosmithkline Biolog Sa | Liposome production using isopropanol |
| WO2013090897A1 (en) * | 2011-12-15 | 2013-06-20 | The Trustees Of The University Of Pennsylvania | Using adaptive immunity to detect drug resistance |
| CN104211787A (zh) * | 2013-05-31 | 2014-12-17 | 中国医学科学院病原生物学研究所 | 用于结核病诊断和预防的蛋白 |
| GB201405921D0 (en) * | 2014-04-02 | 2014-05-14 | Glaxosmithkline Biolog Sa | Novel methods for inducing an immune response |
| US10295538B2 (en) | 2014-08-15 | 2019-05-21 | Oxford Immunotec Limited | Mycobacterium tuberculosis proteins |
| CN105572352B (zh) * | 2016-02-17 | 2017-07-28 | 遵义医学院附属医院 | 一组结核潜伏感染诊断标志物及其用途 |
| CA3045952A1 (en) | 2016-12-07 | 2018-06-14 | Glaxosmithkline Biologicals Sa | Novel process |
| GB201621686D0 (en) | 2016-12-20 | 2017-02-01 | Glaxosmithkline Biologicals Sa | Novel methods for inducing an immune response |
| GB201707700D0 (en) | 2017-05-12 | 2017-06-28 | Glaxosmithkline Biologicals Sa | Dried composition |
| FR3066920A1 (fr) | 2017-05-30 | 2018-12-07 | Glaxosmithkline Biologicals S.A. | Nouveaux procedes de fabrication d'un adjuvant |
| JP2021504424A (ja) | 2017-12-01 | 2021-02-15 | グラクソスミスクライン バイオロジカルズ ソシエテ アノニム | サポニン精製 |
| CN108866213A (zh) * | 2018-06-29 | 2018-11-23 | 周琳 | 结核分枝杆菌利福平耐药性诊断标志物及其应用 |
| CN109234414B (zh) * | 2018-06-29 | 2022-05-17 | 周琳 | 结核分枝杆菌的对氨基水杨酸耐药性诊断标志物及其应用 |
| CN108950031A (zh) * | 2018-06-29 | 2018-12-07 | 周琳 | 结核分枝杆菌的利福平耐药性诊断标志物及其应用 |
| BR112021024363A2 (pt) | 2019-06-05 | 2022-03-22 | Glaxosmithkline Biologicals Sa | Purificação de saponina |
| PH12021553146A1 (en) * | 2019-06-14 | 2024-04-22 | Statens Seruminstitut | Fusion proteins for tuberculosis vaccines |
| CN112457410B (zh) * | 2020-11-05 | 2023-04-07 | 迈克生物股份有限公司 | 用于结核分枝杆菌感染检测的抗原组合物 |
| DE202022102137U1 (de) | 2022-04-21 | 2022-04-28 | Damayanthi Dalu | Eine neue Zusammensetzung zur Behandlung von Tuberkulose |
| CN115073612B (zh) * | 2022-06-22 | 2024-09-27 | 宁夏大学 | 一种结核分枝杆菌Zera-71cA蛋白纳米颗粒、制备方法及其用途 |
| CN115725607B (zh) * | 2022-07-14 | 2023-11-28 | 山东第一医科大学附属省立医院(山东省立医院) | 一种鼻疽诺卡菌的致病靶基因及其应用 |
| CN120058854A (zh) * | 2025-03-05 | 2025-05-30 | 北京知筹科技有限公司 | 一种调节低密度脂蛋白受体相关蛋白（lrp）的多肽及其应用 |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NZ253137A (en) | 1992-06-25 | 1996-08-27 | Smithkline Beecham Biolog | Vaccine comprising antigen and/or antigenic composition, qs21 (quillaja saponaria molina extract) and 3 de-o-acylated monophosphoryl lipid a. |
| US6458366B1 (en) | 1995-09-01 | 2002-10-01 | Corixa Corporation | Compounds and methods for diagnosis of tuberculosis |
| US6592877B1 (en) | 1995-09-01 | 2003-07-15 | Corixa Corporation | Compounds and methods for immunotherapy and diagnosis of tuberculosis |
| US6613881B1 (en) | 1997-05-20 | 2003-09-02 | Corixa Corporation | Compounds for immunotherapy and diagnosis of tuberculosis and methods of their use |
| BR9909472A (pt) | 1998-04-07 | 2001-09-11 | Corixa Corp | Polipeptìdeo purificado, processo para prevenir tuberculose, e, composição farmacêutica |
| AU2001241738A1 (en) | 2000-02-25 | 2001-09-03 | Corixa Corporation | Compounds and methods for diagnosis and immunotherapy of tuberculosis |
| DE60139963D1 (de) | 2000-06-20 | 2009-10-29 | Corixa Corp | Fusionsproteine aus mycobakterium tuberculosis |
| US7538206B2 (en) | 2001-02-22 | 2009-05-26 | Institut Pasteur | Comparative mycobacterial geneomics as a tool for identifying targets for the diagnosis, prophylaxis or treatment of mycobacterioses |
| US7026465B2 (en) | 2002-02-15 | 2006-04-11 | Corixa Corporation | Fusion proteins of Mycobacterium tuberculosis |
| US20030236393A1 (en) | 2002-03-22 | 2003-12-25 | United States Of America Dept Of Vetrans Affairs | Virulence genes of M. marinum and M. tuberculosis |
| WO2005076010A2 (en) | 2004-02-06 | 2005-08-18 | Council Of Scientific And Industrial Research | Computational method for identifying adhesin and adhesin-like proteins of therapeutic potential |
| KR20130110233A (ko) * | 2005-04-29 | 2013-10-08 | 글락소스미스클라인 바이오로지칼즈 에스.에이. | 결핵균 감염을 예방 또는 치료하기 위한 신규한 방법 |
| WO2008007942A1 (en) | 2006-07-10 | 2008-01-17 | Het Nederlands Kanker Instituut | Means and methods for manipulating sequential phagolysomal-cytosolic translocation of mycobacteria, and uses thereof |
| HUE031411T2 (en) | 2007-03-02 | 2017-07-28 | Glaxosmithkline Biologicals Sa | New Methods and Preparations |
| WO2010010178A1 (en) | 2008-07-25 | 2010-01-28 | Glaxosmithkline Biologicals S.A | The tuberculosis rv2707c protein, compositions and uses thereof |
| LT2315597T (lt) | 2008-07-25 | 2018-02-12 | Glaxosmithkline Biologicals S.A. | Naujos kompozicijos ir būdai |
| PT2315834T (pt) * | 2008-07-25 | 2018-08-10 | Glaxosmithkline Biologicals Sa | A proteína rv2386c de tuberculose, composições e as suas utilizações |
| SI2315773T1 (sl) | 2008-07-25 | 2016-12-30 | Glaxosmithkline Biologicals S.A. | Polipeptidi, polinukleotidi in sestavki za uporabo pri zdravljenju latentne tuberkuloze |
| TR201903223T4 (tr) | 2009-04-24 | 2019-03-21 | Statens Seruminstitut | Reaktivasyonu önlemek üzere bir tüberküloz TB aşısı. |
| WO2010132112A2 (en) | 2009-05-14 | 2010-11-18 | Wisconsin Alumni Research Foundation | Immunogenic compositions against tuberculosis |
| HRP20161608T1 (hr) | 2010-01-27 | 2017-01-13 | Glaxosmithkline Biologicals Sa | Modificirani tuberkulozni antigeni |
-
2009
- 2009-07-24 PT PT97810576T patent/PT2315834T/pt unknown
- 2009-07-24 CN CN200980138405.9A patent/CN102165064B/zh active Active
- 2009-07-24 MX MX2011000982A patent/MX2011000982A/es active IP Right Grant
- 2009-07-24 CA CA2731547A patent/CA2731547C/en active Active
- 2009-07-24 EP EP09781057.6A patent/EP2315834B1/en active Active
- 2009-07-24 KR KR1020117004639A patent/KR20110049834A/ko not_active Ceased
- 2009-07-24 SI SI200931869T patent/SI2315834T1/sl unknown
- 2009-07-24 AU AU2009273132A patent/AU2009273132B2/en not_active Ceased
- 2009-07-24 CN CN201710068231.XA patent/CN106866801A/zh active Pending
- 2009-07-24 JP JP2011519186A patent/JP5981138B2/ja active Active
- 2009-07-24 EA EA201100070A patent/EA201100070A1/ru unknown
- 2009-07-24 DK DK09781057.6T patent/DK2315834T3/en active
- 2009-07-24 UA UAA201100300A patent/UA107329C2/uk unknown
- 2009-07-24 BR BRPI0916704-8A patent/BRPI0916704A2/pt not_active IP Right Cessation
- 2009-07-24 ES ES09781057.6T patent/ES2685498T3/es active Active
- 2009-07-24 HU HUE09781057A patent/HUE039159T2/hu unknown
- 2009-07-24 PL PL09781057T patent/PL2315834T3/pl unknown
- 2009-07-24 HR HRP20181353TT patent/HRP20181353T1/hr unknown
- 2009-07-24 US US13/055,787 patent/US20110206712A1/en not_active Abandoned
- 2009-07-24 LT LTEP09781057.6T patent/LT2315834T/lt unknown
- 2009-07-24 WO PCT/EP2009/059585 patent/WO2010010179A1/en not_active Ceased
-
2011
- 2011-01-12 IL IL210589A patent/IL210589A/en not_active IP Right Cessation
- 2011-01-27 CO CO11009237A patent/CO6351811A2/es not_active Application Discontinuation
-
2013
- 2013-06-27 US US13/929,232 patent/US20140086948A1/en not_active Abandoned
-
2014
- 2014-05-21 US US14/283,727 patent/US9480735B2/en active Active
-
2015
- 2015-07-03 JP JP2015134587A patent/JP6104326B2/ja not_active Expired - Fee Related
-
2016
- 2016-09-15 US US15/266,220 patent/US10286053B2/en active Active
-
2018
- 2018-08-24 CY CY20181100883T patent/CY1121632T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011528896A5 (enExample) | ||
| JP2011528895A5 (enExample) | ||
| JP2011528897A5 (enExample) | ||
| JP2012126742A5 (enExample) | ||
| JP2012136541A5 (enExample) | ||
| JP2013231081A5 (enExample) | ||
| HRP20161458T1 (hr) | Polipeptidi, polinukleotidi i pripravci namijenjeni upotrebi u liječenju latentne tuberkuloze | |
| CA2818990C (en) | Designed repeat proteins binding to serum albumin | |
| JP2011136997A5 (enExample) | ||
| JP2012115277A5 (enExample) | ||
| JP2014051497A5 (enExample) | ||
| JP2011500073A5 (enExample) | ||
| JP2014507144A5 (ja) | 慢性ｂ型肝炎感染症のための酵母系免疫療法組成物 | |
| JP2008529558A5 (enExample) | ||
| JP2008536483A5 (enExample) | ||
| FI3581650T3 (fi) | IX-tekijän polypeptidimutantti, sen käyttöjä ja menetelmä sen valmistamiseksi | |
| JP2008508859A5 (enExample) | ||
| JP2008530245A5 (enExample) | ||
| JP2015096557A5 (enExample) | ||
| JP2009213477A5 (enExample) | ||
| JP2015510393A5 (enExample) | ||
| JP2010503396A5 (enExample) | ||
| JP2015517489A5 (enExample) | ||
| JP2011530309A5 (enExample) | ||
| JP2014529399A5 (enExample) |